Seres Therapeutics, Inc. (MCRB)
Pharmaceutical Preparations · Healthcare · $57M
Intrinsic Value (Consensus)
$9.05
Current Price
$5.97
Margin of Safety
+51.6%
51.6% Below Intrinsic Value
Value: $9
Price: $6
Valuation Model Estimates
Current Price: $5.97
DCF (Discounted Cash Flow)
$1.42
Graham Number
$8.15
Earnings Power Value
$6.21
Relative Value (P/E)
$12.80
Dividend Discount Model
Not applicable
—
Consensus Value
$9.05
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
56
Profitability
18/25
Strength
12/25
Valuation
22/25
Growth
4/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 249% (above 200% is risky)
Declining revenue — top line is shrinking
Key Financials
- EPS (TTM)
- $0.64
- EPS (Forward)
- $0.67
- Book Value
- $4.61
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 12.9%
- Debt/Equity
- 249%
- Revenue Growth
- -95.0%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance